Re-usable Respimat® Soft MistTM Inhaler Study

CompletedOBSERVATIONAL
Enrollment

262

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

February 13, 2020

Study Completion Date

February 13, 2020

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Respimat

Soft Mist Inhaler product

Trial Locations (20)

1090

Brussels - UNIV UZ Brussel, Brussels

2650

Hvidovre Hospital, Hvidovre

6041

Clinique Notre-Dame de Grâce, Gosselies

7100

Vejle Hospital, Vejle

8930

Roeselare - HOSP AZ Delta, Menen

12203

MECS Research GmbH, Berlin, Berlin

20520

TYKS, Keuhkosairauksien klinikka, Turku, Turku

23558

Pneumologische Schwerpunktpraxis, 23558 Lübeck, Lübeck

52074

Universitätsklinikum Aachen, AöR, Aachen

56068

KPPK GmbH, Studienzentrum, Koblenz

04207

Pneumologiezentrum Leipzig, Leipzig

4818 CK

Amphia Ziekenhuis, Breda

6419 PC

Zuyderland Medisch Centrum, Heerlen

8934 AD

Medisch Centrum Leeuwarden, Leeuwarden

3045 PM

Franciscus Gasthuis, Rotterdam

7207 AE

Gelre Ziekenhuis Zutphen, Zutphen

N-2402

Frisk Utvikling Helse AS, Elverum

N-4816

Hisøy Legesenter, Kolbjørnsvik

N-1157

Lambertseter Legesenter, Oslo

N-3060

Svelvik Legesenter, Svelvik

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY